NCT01368224View on ClinicalTrials.gov

Two Supplemented Against Skin Reactivity

PHASE3CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Skin SensitivityTrans-epidermal Water LossClinical ScoreAssessment of Skin Moisturization FactorsAssessment of Serum Immune-regulatory CytokineEvaluation of Intestinal Flora Composition
Interventions
DIETARY_SUPPLEMENT

Lactobacillus paracasei NCC 2461 and Bifidobacterium longum NCC3001

"1 treatment unit, in the form of a sachet of powder, to be reconstituted in a glass of water and taken once daily for 8 weeks (from D1 to D57), except if the last visit is bring forward or put back for no more than 3 days, in which case the subject will continue treatment until the final visit.~Oral route."

Trial Locations (1)

69623

DERMSCAN - PharmaScan, Villeurbanne

All Listed Sponsors
collaborator

Société des Produits Nestlé (SPN)

INDUSTRY

lead

L'Oreal

INDUSTRY

NCT01368224 - Two Supplemented Against Skin Reactivity | Biotech Hunter | Biotech Hunter